Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001824293-21-000010
Filing Date
2021-08-10
Accepted
2021-08-10 08:09:29
Documents
53
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ck0001824293-20210630.htm   iXBRL 10-Q 588086
2 EX-31.1 ex311_ceo302cert.htm EX-31.1 11198
3 EX-31.2 ex312_cfo302cert.htm EX-31.2 11195
4 EX-32.1 ex321_ceosection906cert.htm EX-32.1 5788
5 EX-32.2 ex322_cfosection906cert.htm EX-32.2 5772
11 GRAPHIC ck0001824293-20210630_g1.jpg GRAPHIC 95792
  Complete submission text file 0001824293-21-000010.txt   3160796

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ck0001824293-20210630.xsd EX-101.SCH 21542
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ck0001824293-20210630_cal.xml EX-101.CAL 31939
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ck0001824293-20210630_def.xml EX-101.DEF 74087
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ck0001824293-20210630_lab.xml EX-101.LAB 285866
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ck0001824293-20210630_pre.xml EX-101.PRE 193526
12 EXTRACTED XBRL INSTANCE DOCUMENT ck0001824293-20210630_htm.xml XML 341400
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40034 | Film No.: 211158488
SIC: 2834 Pharmaceutical Preparations